[肝硬化中的凝血障碍 - 诊断和管理]
Philipp Kasper1, Frank Tacke2, Guido Michels3
1Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Köln, Köln.
Deutsche medizinische Wochenschrift (1946)
|August 2, 2024
概括
肝硬化患者有复杂的静血变化,增加出血和血栓形成的风险. 在侵袭性手术之前,个性化的方法对于管理凝血至关重要,避免常规纠正.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 临床凝血 临床凝血
背景情况:
- 肝硬化导致复杂的静血系统变化,导致出血和血栓风险.
- 补偿性肝硬化可能呈现出重新平衡的静血状态,而脱补偿会破坏这种平衡.
- 传统的凝血试验不足以评估与肝硬化相关的静血复杂性.
研究的目的:
- 审查肝硬化时静血系统的病理生理变化.
- 提供用于评估凝血状态的诊断方法的概述.
- 讨论治疗策略的出血和血栓性并发症在肝硬化.
主要方法:
- 关于肝硬化中血液静止的病理生理变化的文献综述.
- 对诊断方法的分析,包括常规和功能测试.
- 综合治疗方法来管理静血并发症.
主要成果:
- 肝硬化会导致血静促和抗血静因素的复杂变化.
- 功能性测试,如粘弹性测试和血栓生成测试,比传统测试提供了更好的洞察力.
- 建议采用个性化,基于风险的方法来控制血液静止,特别是在侵入性手术之前.
结论:
- 了解肝硬化中复杂的静血变化对于患者管理至关重要.
- 功能凝血分析优于常规测试,用于评估肝硬化中的静血状态.
- 量身定制的预防措施对于减轻肝硬化患者出血和血栓风险至关重要.
更多相关视频
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
162
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.1K
相关概念视频
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Disorders of Hemostasis
781
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
781
Anticoagulant Drugs: Low-Molecular-Weight Heparins
659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
Diseases of the Liver and Gallbladder
499
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
499
Esophageal Varices-I: Introduction
100
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
100
Coagulation
5.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.9K
